The clinical relevance of ZIP1+ fibroblasts in lung cancer chemoresistance was further investigated in a cohort of 90 lung adenocarcinoma patients who underwent chemotherapy (Supplementary Data 5). The gene discussed is SLC39A1; the disease is lung adenocarcinoma.